EP4188418

DRUG-SPECIFIC PHARMACOKINETIC ASSAY FOR IL-15 SUPERAGONIST

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    21.7.2021
  • EP published:
    2.4.2025
  • EP application number:
    21762839.5
  • Max expiry date:
    20.7.2041
  • Title in English:
    DRUG-SPECIFIC PHARMACOKINETIC ASSAY FOR IL-15 SUPERAGONIST
  • Language of the patent:
    English

Timeline

Today
21.7.2021EP application
2.4.2025EP Publication

Owner

  • Name:
    Nantcell, Inc.
  • Address:
    9920 Jefferson Boulevard, Culver City, California 90232, US

Inventor

  • Name:
    TANAKA, Shiho
  • Address:
    Culver City, California 90232, US
  • Name:
    NIAZI, Kayvan
  • Address:
    Culver City, California 90232, US

Priority

  • Number:
    202063060256 P
  • Date:
    3.8.2020
  • Country:
    US

Classification

  • Categories:
    A61K 38/20, G01N 33/50

Upload documents